ACCESSION: MSBNK-SMB_Measured-HSA001P0211022
RECORD_TITLE: Uncharacterized; LC-ESI-QFT; MS2; POSITIVE; Averaged data
DATE: 2025.03.04 (Averaged 2025.02.14, Processed 2025.02.14, Annotated 2025.02.21, Curated 2025.03.04)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Shin-MassBank project in preparation
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: REPOSITORY MB-POST
COMMENT: DATASET_ID MPST000004
COMMENT: DATASET_TITLE Annotation of various metabolites in SRM 1950 human serum
COMMENT: DATASET_AUTHORS Masatomo Takahashi, Yoshihiro Izumi, Kyushu University
COMMENT: MS1_M/Z_AVERAGED_THRES 0.750
COMMENT: MS2_M/Z_AVERAGED_THRES 4.000
COMMENT: DATASET_FILE_NUM 22
COMMENT: NUM_AVERAGED_SPEC 10
COMMENT: RAW_SPEC {'11_posi_8915': {'bp': 307693.0, 'sum': 461845.0}, '12_posi_9228': {'bp': 232607.0, 'sum': 344691.0}, '15_posi_9121': {'bp': 246047.0, 'sum': 363477.0}, '19_posi_9434': {'bp': 193761.0, 'sum': 280973.0}, '19_posi_8944': {'bp': 263670.0, 'sum': 414436.0}, '19_posi_9226': {'bp': 255453.0, 'sum': 380017.0}, '10_posi_9166': {'bp': 235077.0, 'sum': 363016.0}, '17_posi_9266': {'bp': 215605.0, 'sum': 320362.0}, '19_posi_9083': {'bp': 233332.0, 'sum': 362337.0}, '15_posi_9499': {'bp': 212537.0, 'sum': 329831.0}}
COMMENT: RETENTION_TIME_STDEV 0.377
COMMENT: PRECURSOR_M/Z_RAW 211.154839
COMMENT: PRECURSOR_M/Z_STDEV 0.000072
COMMENT: PRECURSOR_IN_MS1 mz 211.155203; int 83.421; delta(ppm) 1.057000
COMMENT: PROPOSED_CHARGE_STATE +1; mz 212.158573; int 8.445; cor 0.700
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_ION_FORM M+H; M+NH4; mz 228.181752; int 37.221; cor 0.903
COMMENT: PROPOSED_ION_FORM M+H; M+CH3OH+H; mz 243.181480; int 14.529; cor 0.933
COMMENT: PROPOSED_ION_FORM M+H; M+ACN+H; mz 252.181861; int 32.729; cor 0.915
COMMENT: PROPOSED_ION_FORM M+H; M+2ACN+H; mz 293.208268; int 7.091; cor 0.738
COMMENT: PROPOSED_ION_FORM M+Na; M+ACN+Na; mz 252.181861; int 32.729; cor 0.915
COMMENT: PROPOSED_ION_FORM M+CH3OH+H; M+NH4; mz 196.155357; int 12.188; cor 0.767
COMMENT: PROPOSED_ION_FORM M+ACN+H; M+H; mz 170.128667; int 84.114; cor 0.939
COMMENT: PROPOSED_ION_FORM M+ACN+H; M+NH4; mz 187.155209; int 51.168; cor 0.782
COMMENT: PROPOSED_ION_FORM M+ACN+H; M+CH3OH+H; mz 202.154908; int 6.863; cor 0.612
COMMENT: PROPOSED_ION_FORM M+ACN+H; M+2ACN+H; mz 252.181861; int 32.729; cor 0.915
COMMENT: PROPOSED_ION_FORM M+ACN+Na; M+Na; mz 170.128667; int 84.114; cor 0.939
COMMENT: PROPOSED_ION_FORM M+2ACN+H; M+H; mz 129.102139; int 31.296; cor 0.717
COMMENT: PROPOSED_ION_FORM M+2ACN+H; M+NH4; mz 146.128710; int 178.828; cor 0.939
COMMENT: PROPOSED_ION_FORM M+2ACN+H; M+ACN+H; mz 170.128667; int 84.114; cor 0.939
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.638; C10H18N4O; [M+H]+; delta(ppm) -0.637646
COMMENT: PROPOSED_MF SevenGoldenRules 0.741; C9H14N4; [M+CH3OH+H]+; delta(ppm) -0.741066
COMMENT: PROPOSED_MF MS-FINDER 2.221; C10H18N4O; [M+H]+; delta(ppm) -0.637719
COMMENT: PROPOSED_MF SIRIUS5_Sirius 3.073; C10H18N4O; [M+H]+; delta(ppm) -0.637719
COMMENT: PROPOSED_MF SIRIUS5_Sirius 3.073; C8H15N3O; [M+C2H3N+H]+; delta(ppm) -0.637719
COMMENT: PROPOSED_MF SIRIUS5_Sirius 3.073; C9H14N4; [M+CH4O+H]+; delta(ppm) -0.637719
COMMENT: PROPOSED_MF SIRIUS5_Sirius 2.936; C8H18O4; [M+CH4O+H]+; delta(ppm) 5.696109
COMMENT: PROPOSED_MF SIRIUS5_Sirius -4.331; C12H20NO2; [M+H]+; delta(ppm) -6.996328
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C10H18N4O; [M+H]+; delta(ppm) -0.637719
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C8H15N3O; [M+C2H3N+H]+; delta(ppm) -0.637719
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 0.990; C9H14N4; [M+CH4O+H]+; delta(ppm) -0.637719
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 0.010; C8H18O4; [M+CH4O+H]+; delta(ppm) 5.696109
COMMENT: PROPOSED_MF SIRIUS6_Sirius 3.936; C8H18O4; [M+CH4O+H]+; delta(ppm) 5.696109
COMMENT: PROPOSED_MF SIRIUS6_Sirius 2.462; C6H12N2O; [M+C4H6N2+H]+; delta(ppm) -0.637719
COMMENT: PROPOSED_MF SIRIUS6_Sirius 2.462; C10H18N4O; [M+H]+; delta(ppm) -0.637719
COMMENT: PROPOSED_MF SIRIUS6_Sirius 2.462; C9H14N4; [M+CH4O+H]+; delta(ppm) -0.637719
COMMENT: PROPOSED_MF SIRIUS6_Sirius 2.462; C8H15N3O; [M+C2H3N+H]+; delta(ppm) -0.637719
COMMENT: PROPOSED_MF SIRIUS6_Sirius -1.199; C10H22NO2; [M+Na]+; delta(ppm) 44456.305347
COMMENT: PROPOSED_MF SIRIUS6_Sirius -1.199; C8H19O2; [M+C2H3N+Na]+; delta(ppm) 44456.305347
COMMENT: PROPOSED_MF SIRIUS6_Sirius -1.216; C7H19FN4O2; [M+H]+; delta(ppm) -6.049123
COMMENT: PROPOSED_MF SIRIUS6_Sirius -1.216; C6H15FN4O; [M+CH4O+H]+; delta(ppm) -6.049123
COMMENT: PROPOSED_MF SIRIUS6_Sirius -1.533; C7H19N2OP; [M+CH4O+H]+; delta(ppm) -8.460172
COMMENT: PROPOSED_MF SIRIUS6_Sirius -1.819; C8H19ClN2; [M+CH4O+H]+; delta(ppm) -102067.757605
COMMENT: PROPOSED_MF SIRIUS6_Sirius -3.331; C12H20NO2; [M+H]+; delta(ppm) -6.996328
COMMENT: PROPOSED_MF SIRIUS6_Sirius -3.331; C11H16NO; [M+CH4O+H]+; delta(ppm) -6.996328
COMMENT: PROPOSED_MF SIRIUS6_Sirius -3.331; C10H17O2; [M+C2H3N+H]+; delta(ppm) -6.996328
COMMENT: PROPOSED_MF SIRIUS6_Sirius -4.172; C4H10N5; [M+C4H6N2+H]+; delta(ppm) 5.720971
COMMENT: PROPOSED_MF SIRIUS6_Sirius -4.172; C8H16N7; [M+H]+; delta(ppm) 5.720971
COMMENT: PROPOSED_MF SIRIUS6_Sirius -4.172; C6H13N6; [M+C2H3N+H]+; delta(ppm) 5.720971
COMMENT: PROPOSED_MF SIRIUS6_Sirius -4.408; C6H21N5OP; [M+H]+; delta(ppm) -2.101581
COMMENT: PROPOSED_MF SIRIUS6_Sirius -4.408; C5H17N5P; [M+CH4O+H]+; delta(ppm) -2.101581
COMMENT: PROPOSED_MF SIRIUS6_Sirius -6.883; C4H19N8P; [M+H]+; delta(ppm) 4.257090
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C10H22NO2; [M+Na]+; delta(ppm) 44456.305347
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C10H18N4O; [M+H]+; delta(ppm) -0.637719
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C8H19O2; [M+C2H3N+Na]+; delta(ppm) 44456.305347
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C8H15N3O; [M+C2H3N+H]+; delta(ppm) -0.637719
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.998; C6H12N2O; [M+C4H6N2+H]+; delta(ppm) -0.637719
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.883; C9H14N4; [M+CH4O+H]+; delta(ppm) -0.637719
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.113; C8H18O4; [M+CH4O+H]+; delta(ppm) 5.696109
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.002; C4H10N5; [M+C4H6N2+H]+; delta(ppm) 5.720971
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.002; C6H15FN4O; [M+CH4O+H]+; delta(ppm) -6.049123
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.002; C8H19ClN2; [M+CH4O+H]+; delta(ppm) -102067.757605
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.001; C7H19N2OP; [M+CH4O+H]+; delta(ppm) -8.460172
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; OPGDLXLANFEESO-UHFFFAOYSA-N; [M+CH3OH+H]+; 1-(pyrimidin-2-yl)piperidin-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.141; USLXJAKPMUUGPV-UHFFFAOYSA-N; [M+CH3OH+H]+; 1-pyrimidin-2-ylpiperidin-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.838; VBBGHNGROGZGHG-UHFFFAOYSA-N; [M+CH3OH+H]+; 5-piperazin-1-ylpyridin-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.491; YKOUFZWBCNJRRJ-UHFFFAOYSA-N; [M+H]+; 3-ethyl-5-(1-piperazin-1-ylethyl)-1,2,4-oxadiazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.480; AELNGSYDNICUTH-UHFFFAOYSA-N; [M+H]+; 2-(4,5-dipropyl-1,3-oxazol-2-yl)guanidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.290; LZOGPVCTSDAYIP-UHFFFAOYSA-N; [M+CH3OH+H]+; 1-pyrimidin-2-yl-1,4-diazepane
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.196; NMLWFEJUWANVHA-UHFFFAOYSA-N; [M+CH3OH+H]+; 2-(2-phenylethylamino)guanidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.183; MCAIXMIIMYVJOQ-UHFFFAOYSA-N; [M+CH3OH+H]+; N-ethyl-N-(pyridin-3-yldiazenyl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.048; VFKFPZJOKUVRGP-UHFFFAOYSA-N; [M+H]+; 1-(3-morpholin-4-ylpropyl)pyrazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.012; NGTJLOBAXHHPJR-UHFFFAOYSA-N; [M+CH3OH+H]+; 1-amino-2-[(4-methylphenyl)methyl]guanidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.940; IRRRCRKDFMWWNV-UHFFFAOYSA-N; [M+H]+; 2-(3-tert-butyl-1H-1,2,4-triazol-5-yl)morpholine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.821; WYEQVNKICBCRPY-UHFFFAOYSA-N; [M+CH3OH+H]+; 2-methyl-4-piperazin-1-ylpyrimidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.760; UMSBILFYXUYRGS-UHFFFAOYSA-N; [M+CH3OH+H]+; 2-(piperazin-1-ylmethyl)pyrazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.737; ZTSWAKFFINVIES-UHFFFAOYSA-N; [M+CH3OH+H]+; 4-piperazin-1-ylpyridin-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.722; IXGMLJQYJGATJH-UHFFFAOYSA-N; [M+H]+; N,4-diethyl-6-propan-2-yloxy-1,3,5-triazin-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.715; LBHRMKQRUZNCFD-UHFFFAOYSA-N; [M+CH3OH+H]+; N-ethyl-5,6,7,8-tetrahydropyrido[4,3-c]pyridazin-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.713; IHQKKOYVYPDVJE-UHFFFAOYSA-N; [M+CH3OH+H]+; 4-pyridin-2-ylpiperazin-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.673; DMTHAPGLGQMHGT-UHFFFAOYSA-N; [M+CH3OH+H]+; 6-methyl-2-pyrrolidin-1-ylpyrimidin-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.664; ZAYPNVUOUHTVIV-SOFGYWHQSA-N; [M+CH3OH+H]+; [(5E)-5-(dimethylaminomethylidene)-3,4-dihydro-2H-pyridin-6-yl]cyanamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.641; QGYMAHRAAGMMDJ-UHFFFAOYSA-N; [M+CH3OH+H]+; 1-pyrazin-2-ylpiperidin-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.635; AYHGBQRVBWIMAJ-UHFFFAOYSA-N; [M+CH3OH+H]+; 1-pyrimidin-4-ylpiperidin-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.629; OPGDLXLANFEESO-UHFFFAOYSA-N; [M+CH3OH+H]+; 1-pyrimidin-2-ylpiperidin-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.623; ZBCYZACWPLIDGY-UHFFFAOYSA-N; [M+CH3OH+H]+; 2-(2-methylpiperazin-1-yl)pyrazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.607; UIYIEUWPSAMPNA-UHFFFAOYSA-N; [M+CH3OH+H]+; 2-methyl-3-piperazin-1-ylpyrazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.603; PJYCUGCUXXCKCV-UHFFFAOYSA-N; [M+CH3OH+H]+; N,N-dimethyl-5,6,7,8-tetrahydropyrido[4,3-d]pyrimidin-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.592; FUKIEUOIMIWRNK-UHFFFAOYSA-N; [M+CH3OH+H]+; N,N-dimethyl-5,6,7,8-tetrahydropyrido[4,3-c]pyridazin-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.572; CDMVQRUGJHHERZ-UHFFFAOYSA-N; [M+CH3OH+H]+; 4-cyclopropyl-1-pyrrolidin-3-yltriazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.564; DCOORNZXFCKEKZ-UHFFFAOYSA-N; [M+H]+; 4-butoxy-N-ethyl-6-methyl-1,3,5-triazin-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.554; XCVYBHZBTJHKRV-UHFFFAOYSA-N; [M+CH3OH+H]+; N,N-dimethyl-5,6,7,8-tetrahydropyrido[4,3-d]pyrimidin-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.552; RJYISRFFNVECTQ-UHFFFAOYSA-N; [M+CH3OH+H]+; (4,5-dicyclopropyl-1,2,4-triazol-3-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.549; CUXJQEPOWXJYHL-UHFFFAOYSA-N; [M+H]+; 4-ethoxy-6-ethyl-N-propan-2-yl-1,3,5-triazin-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.533; ADQSRWKNIJOPSQ-UHFFFAOYSA-N; [M+H]+; 3-(1-propan-2-yltriazol-4-yl)piperidin-3-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.515; DMZOQRUBOAQWEH-UHFFFAOYSA-N; [M+CH3OH+H]+; (2-pyrrolidin-1-ylpyrimidin-4-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.509; PHGCLLXPEBPSET-UHFFFAOYSA-N; [M+H]+; 2-piperidin-4-yl-5-propan-2-yl-4H-1,2,4-triazol-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.502; UISFBSBIRVFSEF-UHFFFAOYSA-N; [M+CH3OH+H]+; 2-N-cyclobutyl-2-N-methylpyrazine-2,5-diamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.496; DJYZSNKLDXAWIV-UHFFFAOYSA-N; [M+H]+; 5-(piperazin-1-ylmethyl)-3-propan-2-yl-1,2,4-oxadiazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.493; KBIPXRKUZZOFHD-YUMQZZPRSA-N; [M+H]+; 3-[[(1S,2S)-2-aminocyclohexyl]methyl]-4-methyl-1H-1,2,4-triazol-5-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.458; UMSQMUZGSTUAHL-UHFFFAOYSA-N; [M+H]+; N,N,4-triethyl-6-methoxy-1,3,5-triazin-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.430; PTFRHAMKQKTEMK-UHFFFAOYSA-N; [M+H]+; 3-(1,4-diazepan-1-ylmethyl)-5-ethyl-1,2,4-oxadiazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.430; ZCDIOCPFJFEXGB-UHFFFAOYSA-N; [M+H]+; 1-[(5-ethyl-1,2,4-oxadiazol-3-yl)methyl]piperidin-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.237; WGNULDMOVQJCAF-UHFFFAOYSA-N; [M+H]+; 4-[2-(diethylamino)ethoxy]pyrimidin-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.143; MYBOSVWEIVQZFM-UHFFFAOYSA-N; [M+H]+; 4-amino-5-methyl-N-(3-methylbutyl)-1H-pyrazole-3-carboxamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -167.803; YSVNCRFDSYRKBM; [M+C2H3N+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -190.375; DCOORNZXFCKEKZ; [M+H]+; 4-Butoxy-N-ethyl-6-methyl-1,3,5-triazin-2-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -204.475; USLXJAKPMUUGPV; [M+CH4O+H]+; 1-pyrimidin-2-ylpiperidin-4-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -204.802; WASNZWYTDZEYJN; [M+C2H3N+H]+; 2,4,9-Triazaspiro[5.5]undecan-3-one
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -211.773; UMSQMUZGSTUAHL; [M+H]+; N,N,4-Triethyl-6-methoxy-1,3,5-triazin-2-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -219.115; VBBGHNGROGZGHG; [M+CH4O+H]+; 5-(piperazin-1-yl)pyridin-2-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -222.715; ZTSWAKFFINVIES; [M+CH4O+H]+; 4-piperazin-1-ylpyridin-3-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -223.092; CUXJQEPOWXJYHL; [M+H]+; 4-ethoxy-6-ethyl-N-propan-2-yl-1,3,5-triazin-2-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -223.476; IXGMLJQYJGATJH; [M+H]+; N,4-diethyl-6-propan-2-yloxy-1,3,5-triazin-2-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -242.818; XAGVJEZKKSMIHV; [M+C2H3N+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -260.227; ZJFGPATYHVYXMQ; [M+C2H3N+H]+; 1-(2-Oxazolinylamino)piperidine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -267.789; PJYCUGCUXXCKCV; [M+CH4O+H]+; Pyrido[4,3-d]pyrimidin-2-amine, 5,6,7,8-tetrahydro-N,N-dimethyl-
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -269.031; FIIVJDIEDSXVNJ; [M+C2H3N+H]+; N-(1-Methylpiperidin-4-ylidene)acetohydrazide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -269.988; TUZICURVJCEKLK; [M+C2H3N+H]+; N-(2-cyanoethyl)-N'',N''-dimethylpropanehydrazide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -276.946; NQHPYDRZSXDOSD; [M+CH4O+H]+; 6-Methyl-5,6,7,8-tetrahydroquinazoline-2,4-diamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -281.638; GXOHKQZNOVLQOK; [M+CH4O+H]+; Oprea1_824132
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -284.395; MCAIXMIIMYVJOQ; [M+CH4O+H]+; m-Pyridyl-diethyl-triazene
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -284.650; HVHHQHTXTGUMSR; [M+H]+; Amibuzin
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -305.690; WGNULDMOVQJCAF; [M+H]+; 2-Amino-4-diethylaminoethoxypyrimidine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -332.775; NMLWFEJUWANVHA; [M+CH4O+H]+; Phenethylguanidine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -338.935; MYBOSVWEIVQZFM; [M+H]+; 4-Amino-5-methyl-N-(3-methylbutyl)-1H-pyrazole-3-carboxamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -382.103; IEYKCXJYWXSHCR; [M+C2H3N+H]+; Hexahydro-3,3-dimethylimidazo(1,5-a)pyrazin-1(5H)-one
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -385.049; AELNGSYDNICUTH; [M+H]+; Guanidine, (4,5-dipropyl-2-oxazolyl)-
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -494.989; ZAYPNVUOUHTVIV; [M+CH4O+H]+; 2-(N-Cyanimino)-3-dimethylaminoethylenepiperidine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -522.685; IOFGATAJWGLVLA; [M+CH4O+H]+; 4-(4-aminocyclohexylidene)imidazol-2-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.167; YSVNCRFDSYRKBM; [M+C2H3N+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.082; DCOORNZXFCKEKZ; [M+H]+; 4-Butoxy-N-ethyl-6-methyl-1,3,5-triazin-2-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.062; USLXJAKPMUUGPV; [M+CH4O+H]+; 1-pyrimidin-2-ylpiperidin-4-amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -113.005; YSBLOYWDBDOOKL; [M+H]+; 1-[3-(1H-imidazol-2-yl)propyl]-3-propylurea
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -114.245; BAFGDFVWLNBALB; [M+H]+; 1-[3-(1H-imidazol-2-yl)propyl]-3-propan-2-ylurea
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -117.606; JGXWXGGBYYNKHA; [M+H]+; 3-amino-N-(2-imidazol-1-ylethyl)-2,2-dimethylpropanamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -117.990; BXCWKIVGSJSONK; [M+H]+; 1-butyl-3-[2-(1H-imidazol-2-yl)ethyl]urea
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -118.332; AUOUNUWANWVPAL; [M+H]+; N-butyl-5-propyl-1H-1,2,4-triazole-3-carboxamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -119.163; UPWSSYRMYOBCFX; [M+H]+; N-(cyclopropylmethyl)-5-(propylaminomethyl)-1,3,4-oxadiazol-2-amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -126.722; FZUPUGZLGNWOTL; [M+H]+; 1-Butyl-3-(2-imidazol-1-ylethyl)urea
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -128.927; LJIGBVYLXUZMNQ; [M+H]+; 3-[3-(Pyrrolidin-3-ylmethyl)-1,2,4-oxadiazol-5-yl]propan-1-amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -130.916; ZKQJYDVLTWDMAV; [M+H]+; 3-amino-N-(3-imidazol-1-ylpropyl)-2-methylpropanamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -131.393; DSZWOFGUUDCVIP; [M+H]+; 3-amino-N-[2-(1H-imidazol-2-yl)ethyl]-2,2-dimethylpropanamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -187.293; UISFBSBIRVFSEF; [M+CH4O+H]+; N2-cyclobutyl-N2-methylpyrazine-2,5-diamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -206.902; NLSOHYYDUQEOAJ; [M+C2H3N+H]+; 4-Amino-3-(3-methylimidazol-4-yl)butan-1-ol
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -208.948; VDEZQKWQEXPHQV; [M+C2H3N+H]+; (2-methoxyethyl)[(1-methyl-1H-pyrazol-5-yl)methyl]amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -220.088; DMZOQRUBOAQWEH; [M+CH4O+H]+; [2-(Pyrrolidin-1-yl)pyrimidin-4-yl]methanamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -220.167; DCBZROKRPNWVEL; [M+CH4O+H]+; 2-(1-Phenylethylamino)guanidine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -227.225; GXOHKQZNOVLQOK; [M+CH4O+H]+; (7s)-7-Methyl-5,6,7,8-Tetrahydroquinazoline-2,4-Diamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -227.738; NQHPYDRZSXDOSD; [M+CH4O+H]+; 6-Methyl-5,6,7,8-tetrahydroquinazoline-2,4-diamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -229.093; UIYIEUWPSAMPNA; [M+CH4O+H]+; 2-Methyl-3-(piperazin-1-yl)pyrazine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -236.240; RAOQMNAYDHVOTA; [M+C2H3N+H]+; 3-[(1,3-dimethyl-1H-pyrazol-5-yl)oxy]propan-1-amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -244.238; NMLWFEJUWANVHA; [M+CH4O+H]+; Phenylethylguanidine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -249.756; PJYCUGCUXXCKCV; [M+CH4O+H]+; N,N-Dimethyl-5,6,7,8-tetrahydropyrido[4,3-D]pyrimidin-2-amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -254.753; ZTSWAKFFINVIES; [M+CH4O+H]+; Piperazine, 1-(3-amino-4-pyridyl)-
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -258.257; MCAIXMIIMYVJOQ; [M+CH4O+H]+; 1-(3-Pyridyl)-3,3-diethyltriazene
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -262.871; YSVNCRFDSYRKBM; [M+C2H3N+H]+; 3-butyl-1,4-dimethyl-4,5-dihydro-1H-1,2,4-triazol-5-one
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -279.755; XAGVJEZKKSMIHV; [M+C2H3N+H]+; 1-[(Pyrrolidin-3-yl)methyl]imidazolidin-2-one
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -288.659; WASNZWYTDZEYJN; [M+C2H3N+H]+; 2,4,9-Triazaspiro[5.5]undecan-3-one
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -317.558; ZJFGPATYHVYXMQ; [M+C2H3N+H]+; 1-(2-Oxazolinylamino)piperidine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -333.479; STPGKUVSQGDNCN; [M+C2H3N+H]+; (1R)-2-amino-1-(trimethyl-1H-pyrazol-4-yl)ethan-1-ol
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -349.363; UTIBMAPIRONOEL; [M+C2H3N+H]+; 1-[(3S)-piperidin-3-yl]imidazolidin-2-one
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -361.521; FIIVJDIEDSXVNJ; [M+C2H3N+H]+; N-(1-Methylpiperidin-4-ylidene)acetohydrazide
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.088; YSBLOYWDBDOOKL; [M+H]+; 1-[3-(1H-imidazol-2-yl)propyl]-3-propylurea
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.053; UISFBSBIRVFSEF; [M+CH4O+H]+; N2-cyclobutyl-N2-methylpyrazine-2,5-diamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.052; NLSOHYYDUQEOAJ; [M+C2H3N+H]+; 4-Amino-3-(3-methylimidazol-4-yl)butan-1-ol
COMMENT: CONFIDENCE Level 5: Exact mass of interest 211.155203; Observed in MS1; Charge state +1;
CH$NAME: Uncharacterized
CH$COMPOUND_CLASS: Uncharacterized
CH$FORMULA: C39H42O2
CH$EXACT_MASS: 542.318480
CH$SMILES: CCCC#Cc1cc(C#CCCC)cc(C#Cc2cc(C#CC(C)(C)C)c(cc2C#CC(C)(C)C)C2OCCO2)c1
CH$IUPAC: InChI=1S/C39H42O2/c1-9-11-13-15-30-25-31(16-14-12-10-2)27-32(26-30)17-18-33-28-35(20-22-39(6,7)8)36(37-40-23-24-41-37)29-34(33)19-21-38(3,4)5/h25-29,37H,9-12,23-24H2,1-8H3
CH$LINK: PUBCHEM CID:11353257
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Serum
AC$INSTRUMENT: Nexera X2 UHPLC system, Shimadzu - Q Exactive Orbitrap, Thermo Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY 20 V
AC$MASS_SPECTROMETRY: COLLISION_GAS N2
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 0.75; MS2(ppm) 4.00
AC$CHROMATOGRAPHY: COLUMN_NAME GL-HilicAex 2.1 x 150 mm, 5 mm (Resonac)
AC$CHROMATOGRAPHY: FLOW_GRADIENT B conc(%). 0 min: 95, 0.5 min: 95, 15.5 min: 40, 16.5 min: 0, 26.5 min: 0, 27.5 min: 95, 35 min: 95.
AC$CHROMATOGRAPHY: FLOW_RATE 0.4 mL/min
AC$CHROMATOGRAPHY: RETENTION_TIME 18.429
MS$FOCUSED_ION: PRECURSOR_M/Z 211.155203
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-03di-0190000000-11abe6117fd9989b7286
PK$ANNOTATION: m/z int annotation m/z_nocal m/z_std(ppm) int_std cor n
  86.0599258 22.5160 ? 86.060393 1.8475 3.57 0.8810 8
  111.0916504 26.4965 ? 111.091866 1.9713 5.19 0.5152 10
  125.0947789 23.7084 ? 125.094820 2.2303 2.38 0.8810 8
  126.1024542 39.9456 ? 126.102481 1.0071 7.35 0.6727 10
  127.0866784 91.5718 ? 127.086691 1.8885 12.19 0.4788 10
  193.1446746 45.9165 ? 193.144545 1.2892 7.12 0.5152 10
  211.1196464 66.1367 ? 211.119506 1.3215 15.47 0.5167 9
  211.1552438 999.0000 ? 211.155103 0.4404 0.00 1.0000 10
  211.1727178 51.2856 ? 211.172577 1.6669 6.69 0.5879 10
PK$NUM_PEAK: 9
PK$PEAK: m/z int. rel.int.
  86.059926 22.52 22
  111.091650 26.50 26
  125.094779 23.71 23
  126.102454 39.95 39
  127.086678 91.57 91
  193.144675 45.92 45
  211.119646 66.14 66
  211.155244 999.00 999
  211.172718 51.29 51
//
